<?xml version="1.0" encoding="UTF-8"?>
<p>Regarding the formulations, the inactivated whole virus Sinovac vaccine is composed of one isolate of Sars-CoV2 (CN2) obtained from a patient of China and Alum adjuvant (
 <xref rid="B40" ref-type="bibr">40</xref>), while the Chadox1 nCoV19 vaccine of Oxford is composed of a Chimpanzee recombinant adenovirus, which expresses the S protein of SARS-Cov2 (
 <xref rid="B39" ref-type="bibr">39</xref>).
</p>
